In the News

January 21, 2025

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

December 20, 2024

Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine Candidate

August 12, 2024

SaponiQx and InvivoGen Launch STIMULON Cultured Plant Cell QS-21 Adjuvant for Commercial Purchase

April 17, 2024

SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant

February 15, 2024

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

January 26, 2024

Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

October 10, 2023

SaponiQx Advances Vaccine Development With the Availability of cGMP QS-21 From Its Proprietary Cultured Plant Cell Source

August 9, 2023

SaponiQx Announces Breakthrough in Scaling Up of STIMULON™ Cultured Plant Cell Adjuvant

April 28, 2023

Watch SaponiQx Presentation at Ginko Ferment Conference, 2023